American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Bethlem & Maudsley NHS Trust (1995) Prescribing Guidelines (2nd edn. 2nd impression), Appendix 1, pp. 21–22. London: Bethlem and Maudsley NHS Trust.
Brylewski, J. & Duggan, L. (1996) Antipsychotic medication for challenging behaviour in people with learning disability (Protocol). In Schizophrenia Module (eds Adams, C. E., Duggan, C., de Jesus Mari, J., et al) The Cochrane Database of Systematic Reviews (available in the Cochrane Library).
London: BMJ Publishing.
Deb, S. & Fraser, W. (1994) The use of psychotropic medication in people with learning disability: towards rationale prescribing. Human Psychopharmacology, 9, 259–272.
Einfeld, S. L. (1990) Guidelines for use of psychotropic medication in individuals with developmental disabilities. Australia and New Zealand Journal of Developmental Disabilities, 16, 71–73.
Fan, T. W. (1991) Prescribing in mental handicap hospitals. British Journal of Psychiatry, 158, 282–292.
Foster, R. P. (1989) Neuroleptic equivalence. Pharmaceutical Journal, 243, 431–432.
Gravestock, S. (1994) Quality assurance for adults with mental retardation and mental health needs. In Mental Health Needs in Mental Retardation (ed. Bouras, N.), pp. 319–327. Cambridge: Cambridge University Press.
Gualtieri, C. T. (1990) Neuropsychiatry and Behavioural Psychopharmacology.
Harvey, R. J. & Cooray, S. E. (1993) Neuroleptic usage in a community mental handicap unit. Psychiatric Bulletin, 17, 657–660.
Hempel, C. G. (1961) Introduction to problems of taxonomy. In Field Studies in the Mental Disorders (ed. Zubin, J.). New York: Grune and Stratton.
Holbrook, J. M., Parks-Veal, P. & Mimbs, J. (1991) Clinical monitoring guidelines for neuroleptic and antidepressant drugs. Hospital Pharmacy, 26, 783–784, 787–793.
Joffe, R. T. & Calabrese, J. R. (eds) (1994) Anticonvulsants in Mood Disorders.
New York: Marcel Dekker.
Matson, J. L., Kazden, A. E. & Sentore, V. (1984) Psychometric properties of the Psychopathology Instrument for Mentally Retarded Adults. Applied Research - Mental Retardation, 5, 81–89.
Matson, J. L., Gardner, W. I., Koe, D. A., et al (1991) A scale for evaluating emotional disorders in severely and profoundly retarded persons: Development of the Diagnostic Assessment for the Severely Handicapped (DASH) scales. British Journal of Psychiatry, 159, 404–429.
Paton, C. & Beer, D. (1996) Blood tests for patients prescribed psychotropics: what, when and why. Psychiatric Bulletin, 20, 356–358.
Royal College of Psychiatrists (1993) Consensus Statement on the Use of High Dose Antipsychotic Medication (Council Report CR26). London: Royal College of Psychiatrists.
Sachdev, P. S. (1991) Psychoactive drug use in an institution for intellectually handicapped persons. Medical Journal of Australia, 155, 75–79.
Sovner, R. (1989) Treating mentally retarded adults with psychotropic drugs: a clinical perspective. In Mental Retardation and Mental Illness (eds Fletcher, R. & Menolascino, F. J.). pp. 157–183. Lexington, MA: Lexington Books.
Sovner, R. (1991) Use of anticonvulsant agents for the treatment of neuropsychiatric disorders in the developmentally disabled. In Mental Retardation: Developing Pharmacotherapies (ed. Ratey, J. J.). pp. 83–106. Washington, DC: American Psychiatric Press.
Sovner, R. & Lowry, M. A. (1995) Pharmacological treatment of chronic behavioural problems in persons with mental retardation. In Research Pharmacological Management of Chronic Psychiatric Disorders (eds Ancill, R. J. & Lader, M. H.) in Baillière's Clinical Psychiatry, pp. 683–703. London: Baillière Tindall Harcourt.
Tohen, M., Castillo, J., Baldessarini, R., et al (1995) Blood dyscrasias with carbamazepine and valproate: A pharmacological study of 2228 patients at risk. American Journal of Psychiatry, 145, 339–342.
World Health Organization (1992) The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD–10).
Wressell, S. E., Tyrer, S. P. & Berney, T. P. (1990) Reduction in antipsychotic drug dosage in mentally handicapped patients: a hospital study. British Journal of Psychiatry, 157, 101–106.